Published in Biol Psychiatry on November 15, 1991
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A (1996) 2.22
Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.94
Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol (2013) 1.52
Sensory processing in schizophrenia: neither simple nor intact. Schizophr Bull (2009) 1.49
Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) (2004) 1.47
Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev (2010) 1.38
Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry (2011) 1.20
Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci (2007) 1.18
Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med (2011) 1.18
Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry (2010) 1.16
Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull (2009) 1.14
A functional magnetic resonance imaging study of auditory mismatch in schizophrenia. Am J Psychiatry (2001) 1.10
How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology (2010) 1.06
Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity. Biol Psychiatry (2013) 1.04
Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses. Neuroimage (2012) 1.00
Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res (2014) 1.00
Mismatch negativity: translating the potential. Front Psychiatry (2013) 0.97
Application of electroencephalography to the study of cognitive and brain functions in schizophrenia. Schizophr Bull (2007) 0.96
The role of the primary auditory cortex in the neural mechanism of auditory verbal hallucinations. Front Hum Neurosci (2013) 0.94
Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behav Brain Res (2009) 0.93
Fast reconfiguration of high-frequency brain networks in response to surprising changes in auditory input. J Neurophysiol (2011) 0.93
Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders. Proc Natl Acad Sci U S A (2013) 0.92
Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia. Biol Psychiatry (2011) 0.92
Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology (Berl) (2007) 0.92
Impaired conscious and preserved unconscious inhibitory processing in recent onset schizophrenia. Psychol Med (2008) 0.90
Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial. PLoS One (2012) 0.90
Evidence for impaired sound intensity processing in schizophrenia. Schizophr Bull (2009) 0.90
Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology (Berl) (2009) 0.89
Mismatch negativity at acute and post-acute phases of first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci (2008) 0.89
Mismatch negativity (MMN) as an index of cognitive dysfunction. Brain Topogr (2014) 0.89
Auditory mismatch negativity deficits in long-term heavy cannabis users. Eur Arch Psychiatry Clin Neurosci (2010) 0.88
Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Ann N Y Acad Sci (2015) 0.87
Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task. Brain Topogr (2009) 0.86
Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses. Biomark Med (2014) 0.86
Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia. Neuroimage Clin (2014) 0.85
Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. Bipolar Disord (2012) 0.85
Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge. J Psychiatry Neurosci (2001) 0.84
Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis. BMC Psychiatry (2013) 0.84
Auditory stream segregation impairments in schizophrenia. Psychophysiology (2012) 0.84
Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster. J Psychiatry Neurosci (2012) 0.84
Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology (2015) 0.84
Abnormal peripheral auditory asymmetry in schizophrenia. J Neurol Neurosurg Psychiatry (2001) 0.83
LORETA current source density for duration mismatch negativity and neuropsychological assessment in early schizophrenia. PLoS One (2013) 0.83
Abnormal pitch mismatch negativity in individuals with schizotypal personality disorder. Schizophr Res (2009) 0.82
Hippocampal event-related potentials to tone duration deviance in a passive oddball paradigm in humans. Neuroimage (2007) 0.82
Cortical mapping of mismatch negativity with deviance detection property in rat. PLoS One (2013) 0.82
Auditory processing abnormalities in schizotypal personality disorder: an fMRI experiment using tones of deviant pitch and duration. Schizophr Res (2008) 0.82
Mismatch negativity latency and cognitive function in schizophrenia. PLoS One (2014) 0.81
Mismatch negativity in recent-onset and chronic schizophrenia: a current source density analysis. PLoS One (2014) 0.80
Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls. Psychopharmacology (Berl) (2007) 0.80
Mismatch negativity/P3a complex in young people with psychiatric disorders: a cluster analysis. PLoS One (2012) 0.80
Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis. Schizophr Res (2015) 0.79
Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. Biol Psychol (2015) 0.79
Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia. PLoS One (2013) 0.78
Delayed preattentional functioning in early psychosis patients with cannabis use. Psychopharmacology (Berl) (2012) 0.76
Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients. Int J Neuropsychopharmacol (2015) 0.76
Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia. Neuropsychopharmacology (2017) 0.75
Fragile temporal prediction in patients with schizophrenia is related to minimal self disorders. Sci Rep (2017) 0.75
Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity. Hum Brain Mapp (2015) 0.75
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology. Transl Psychiatry (2017) 0.75
Neurophysiology for Detection of High Risk for Psychosis. Schizophr Res Treatment (2016) 0.75
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Complete nucleotide sequence of Saccharomyces cerevisiae chromosome VIII. Science (1994) 3.97
Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis. Acta Psychiatr Scand (2008) 2.07
Couch or crouch? Examining the prostate: a randomized study comparing the knee-elbow and the left-lateral position. BJU Int (2001) 2.01
The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. AIDS (2005) 1.72
The reliability of digital images when used to assess burn wounds. J Telemed Telecare (2003) 1.54
Decrement of the N1 auditory event-related potential with stimulus repetition: habituation vs. refractoriness. Int J Psychophysiol (1998) 1.54
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother (2009) 1.50
From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs. Respir Med (2000) 1.44
Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res (1996) 1.43
Perineal trauma from cassette tape boxes. Br J Surg (1992) 1.39
Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am J Psychiatry (1995) 1.29
Disturbed communication in schizophrenia: the role of poor pragmatics and poor mind-reading. Psychol Med (2002) 1.28
Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry (1995) 1.27
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol Psychiatry (2012) 1.27
Acts of control in schizophrenia: dissociating the components of inhibition. Psychol Med (2002) 1.26
Impulsivity in pathological gambling: the antisocial impulsivist. Addiction (1997) 1.22
Patterns of psychiatric morbidity in a genito-urinary clinic. A validation of the Hospital Anxiety Depression scale (HAD). Br J Psychiatry (1988) 1.20
Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res (2000) 1.19
Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. Gastroenterology (1985) 1.18
Boredom proneness in pathological gambling. Psychol Rep (1990) 1.16
Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis. Clin Infect Dis (2001) 1.16
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. Eur J Clin Microbiol Infect Dis (2005) 1.16
Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull (2009) 1.14
Early selective-attention effects on the evoked potential: a critical review and reinterpretation. Biol Psychol (1979) 1.14
Acquired venous aneurysms. Br J Sports Med (1991) 1.07
Profiling bacterial survival through a water treatment process and subsequent distribution system. J Appl Microbiol (2005) 1.07
PCR amplification from fixed tissue indicates frequent involvement of Brachyspira aalborgi in human intestinal spirochetosis. J Clin Microbiol (1999) 1.07
Different fibers have different regional effects on luminal contents of rat colon. Gastroenterology (1991) 1.07
Role of the indigenous medicine practitioner in two areas of India. Report of a study. Soc Sci Med (1971) 1.05
Superior temporal gyral volumes and laterality correlates of auditory hallucinations in schizophrenia. Biol Psychiatry (1999) 1.02
Community treatment orders: relationship to clinical care, medication compliance, behavioural disturbance and readmission. Aust N Z J Psychiatry (2000) 1.00
The anaerobic oxidation of dihydroorotate by Escherichia coli K-12. Biochim Biophys Acta (1977) 1.00
Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol (2008) 0.99
The effects of spatial selective attention on the somatosensory event-related potential. Psychophysiology (1987) 0.98
Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia. Clin Neurophysiol (2003) 0.97
The spatial and temporal dynamics of anticipatory preparation and response inhibition in task-switching. Neuroimage (2010) 0.97
Pathological gamblers, heroin addicts and controls compared on the E.P.Q. 'Addiction Scale'. Br J Addict (1985) 0.97
A controlled trial of imipramine, amphetamine, pad-and-bell conditioning and random awakening in the treatment of nocturnal enuresis. Med J Aust (1969) 0.97
Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol (2004) 0.96
Effects of long-term cannabis use on selective attention: an event-related potential study. Pharmacol Biochem Behav (1991) 0.95
Active and passive attention in schizophrenia: an ERP study of information processing in a linguistic task. Biol Psychol (1992) 0.93
Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance. Oncogene (2012) 0.93
Subjective and penile plethysmograph responses following aversion-relief and apomorphine aversion therapy for homosexual impulses. Br J Psychiatry (1969) 0.93
Sensation seeking and pathological gambling. Br J Addict (1986) 0.93
Controlled comparison of aversive therapy and imaginal desensitization in compulsive gambling. Br J Psychiatry (1983) 0.92
Late-onset depression: genetic, vascular and clinical contributions. Psychol Med (2001) 0.91
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma. Cancer Chemother Pharmacol (2010) 0.91
Facilitation of the N1 peak of the auditory ERP at short stimulus intervals. Neuroreport (1994) 0.91
Event-related potential indices of semantic processing in schizophrenia. Biol Psychiatry (1993) 0.89
Emergence of novel Leptospira serovars: a need for adjusting vaccination policies for dogs? Epidemiol Infect (2012) 0.89
Effects of inter-item lag on word repetition: an event-related potential study. Psychophysiology (1991) 0.89
Familial relationships of allusive thinking in university students and their parents. Br J Psychiatry (1968) 0.89
ERP correlates of response inhibition to elemental and configural stimuli in a negative patterning task. Clin Neurophysiol (2000) 0.89
Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection. J Antimicrob Chemother (2010) 0.86
Defective Self and/or Other Mentalising in Schizophrenia: A Cognitive Neuropsychological Approach. Cogn Neuropsychiatry (1997) 0.86
The independence of neurotic and endogenous depression. Br J Psychiatry (1967) 0.86
Bacteriophages associated with multiresistant Staphylococcus aureus in Australia. J Med Microbiol (1987) 0.85
Brachyspira aalborgi infection in four Australian children. J Gastroenterol Hepatol (2001) 0.85
Campylobacter upsaliensis gastroenteritis in childhood. Pediatr Infect Dis J (1999) 0.85
Penile volume change to moving pictures of male and female nudes in heterosexual and homosexual males. Behav Res Ther (1967) 0.85
Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment. Transl Psychiatry (2013) 0.85
The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse. Soc Psychiatry Psychiatr Epidemiol (1992) 0.84
Frontal processing negativity in a visual selective attention task. Electroencephalogr Clin Neurophysiol (1996) 0.84
Auditory selective attention and event-related potentials in schizophrenia. Br J Psychiatry (1991) 0.84
Purification and properties of 3-deoxy-d-arabinoheptulosonic acid-7-phosphate synthetase (phe) from a lambda aroG+ transductant of Escherichia coli. J Bacteriol (1971) 0.84
High prevalence of gynecologic disease among hospitalized women with human immunodeficiency virus infection. Clin Infect Dis (1997) 0.84
Hazards of domiciliary oxygen therapy. Respir Med (1993) 0.84
Selective attention effects on somatosensory event-related potentials. Ann N Y Acad Sci (1984) 0.84
Genetically distinct strains of Candida albicans with elevated secretory proteinase production are associated with diarrhoea in hospitalized children. J Gastroenterol Hepatol (2000) 0.83
Creativity, divergent and allusive thinking in students and visual artists. Psychol Med (1982) 0.83
The effect of repeated testing on ERP components during auditory selective attention. Psychophysiology (1991) 0.83
The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression. Int J Cancer (2001) 0.83
Selective medium for isolation of Fusarium species and dematiaceous hyphomycetes from cereals. Appl Environ Microbiol (1986) 0.83
An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. Br J Pharmacol (1995) 0.83